United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69306-015_3df3e06d-9fe0-2b90-e063-6294a90ab5af
- Product NDC
- 69306-015
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Doc Rx
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20190304
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69306-015-03) · 69306-015-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →